BIM
DXCM icon

Bridgecreek Investment Management’s DexCom DXCM Stock Holding History

Bridgecreek Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,000
Closed -$384K – 109
2022
Q1 		$384K Hold
3,000
– – 0.06% 102
2021
Q4 		$403K Hold
3,000
– – 0.06% 100
2021
Q3 		$410K Hold
3,000
– – 0.06% 90
2021
Q2 		$320K Hold
3,000
– – 0.05% 91
2021
Q1 		$270K Hold
3,000
– – 0.04% 89
2020
Q4 		$277K Hold
3,000
– – 0.04% 86
2020
Q3 		$309K Buy
+3,000
New +$313K 0.05% 79

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bridgecreek Investment Management's DXCM Position: Q2 2022 in Review

Bridgecreek Investment Management sold out of DexCom (DXCM) in Q2 2022, closing a stake of 3,000 shares — an estimated $384K sold.

Bridgecreek Investment Management first reported a position in DXCM in Q3 2020 and held it in 7 quarters. The position peaked at $410K in Q3 2021. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Bridgecreek Investment Management reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Bridgecreek Investment Management sold 3,000 DexCom shares in Q2 2022, an estimated $384K.
  • Bridgecreek Investment Management first reported a position in DexCom in Q3 2020 and held it in 7 quarters.
  • Bridgecreek Investment Management's DexCom position peaked at $410K in Q3 2021.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Bridgecreek Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.